Conjunctivitis Pharma Focus - Clinical Trial: Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

Article

This clinical trial will determine moxifloxacin's efficacy for treating bacterial conjunctivitis.

Study Type: Interventional

Age/Gender Requirements: 1 month+ (male/female)

Sponsor: Alcon Research

Purpose: To evaluate the safety and efficacy of Moxifloxacin AF Ophthalmic Solution in comparison to Moxifloxacin AF Vehicle for treating bacterial conjunctivitis.

Click here to access this third-party resource.

Recent Videos
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
A panel of 5 experts on iron deficiency anemia
A panel of 5 experts on iron deficiency anemia
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
© 2024 MJH Life Sciences

All rights reserved.